In this episode of Aideation, TPY Capital’s podcast for founders building in the GenAI world, we dive deep into the intersection of AI and computational biology with Dr. Ido Weiner, CSO of Converge Bio. We discuss what computational biology is and how the field evolved, the pivotal moments that shaped it, the current state of the industry, its holy grail and biggest challenges, where the greatest value is being created in AI-driven drug discovery, and at which stages generative models should be applied, from target discovery to molecule and protein design. We also talk about where the money is flowing and what the ecosystem looks like, what the real moat in bio-AI is, why data is everything and how to avoid pitfalls like bias and overfitting, and finally a personal look ahead at what might surprise us in the next two years.